Skip to main content


Latest news

07-09-2022 | Diabetes | News | Article

CLOuD: Early and sustained closed-loop therapy does not stave off beta-cell decline

Starting young people on closed-loop insulin delivery within 21 days after type 1 diabetes diagnosis does not slow the decline in their C-peptide levels over the next 12 months, report the CLOuD investigators.

06-09-2022 | Rheumatology | News | Article

Childhood adiposity link to PsA, SLE risk ‘may not be fully reversible’

Overweight and obesity during childhood may be associated with an increased risk for systemic lupus erythematosus and psoriatic arthritis that persists even if a healthy bodyweight is achieved during adulthood, researchers report.

05-09-2022 | Diabetes | News | Article

Lower screening thresholds may better detect depression in adolescent type 1 diabetes

Reducing the cutoffs of commonly used depression screening measures may increase the sensitivity for detecting depression in adolescents with type 1 diabetes, US study findings indicate.

01-09-2022 | Oncology | News | Article

‘Time to cure’ around 6 years for young ALL patients regardless of risk status

UK researchers have a calculated a “time to cure” of around 6 years after diagnosis for children and young adults with acute lymphoblastic leukaemia, regardless of risk status.

This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.

Follow medwireNews

Click here